Clinical Trials in Nashville

Showing 4461-4480 of 20,298 trials

A Phase 2 Study of YA-101 in Patients With Multiple System Atrophy

NCT06848231

This is a Phase 2, double-blind, placebo-controlled, multi-center, Phase II, dose escalation study to evaluate the safety, tolerability, pharmacokinetics and efficacy of Ya-101 in subjects with multiple system atrophy.

Multiple System Atrophy

Yoda Therapeutics Inc.75 participantsStarted Mar 2025

Los Angeles, California, United States • Boston, Massachusetts, United States • Rochester, Minnesota, United States +6 more locations

Active Not RecruitingPhase 39.2 miles

Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With Cirrhosis

NCT05297448

Study RNLC3132 is a Phase 3, randomized, double-blind, placebo-controlled, multicenter study to assess the efficacy and safety of rifaximin SSD-40mg IR for the delay of the first episode of overt hepatic encephalopathy (OHE) decompensation in liver cirrhosis, defined by the presence of medically controlled ascites.

Hepatic Encephalopathy

Bausch Health Americas, Inc.466 participantsStarted Aug 2022

Homewood, Alabama, United States • Chandler, Arizona, United States • Sun City, Arizona, United States +185 more locations

A Phase 2 Study of YA-101 in Patients With Multiple System Atrophy

Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With Cirrhosis

Find Trials by Condition in Nashville

A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age

Retrospective Study of Suture Tape for Soft Tissue Reconstruction in Patients Suffering From Lateral Ankle Instability

Study With Quadrivalent Recombinant Influenza Vaccine (RIV4) Compared With Egg-Based Quadrivalent Influenza Vaccine (IIV4) in Participants Aged 3 to 8 Years

A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and Azacitidine in Newly Diagnosed AML Ineligible for Intensive Therapy

Abatacept in Immune Checkpoint Inhibitor Myocarditis

A Safety/Tolerability and PK Study With Azstarys® in Children With ADHD

PRI-VENT FSGS: Preemptive Rituximab to Prevent Recurrent Focal Segmental Glomerulosclerosis Post-Transplant

A Study to Evaluate the Effect of Deucravacitinib on Quality of Life in Participants With Plaque Psoriasis in a Community Setting

A Study of Efficacy and Safety of Pembrolizumab Plus Enfortumab Vedotin (EV) +/- Investigational Agents in First-Line Metastatic Urothelial Carcinoma (mUC) (MK-3475-04B/KEYMAKER-U04)

Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants

Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupus

A Study of LM-24C5 For Advanced Solid Tumors

A Study to Evaluate Efficacy and Safety of Deucravacitinib in Participants With Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer

LiveSMART Trial to Prevent Falls in Patients With Cirrhosis